"The Directors of MGC Pharmaceuticals Ltd (the “Company”request that the Company’s securities be placed in a
voluntary trading halt immediately in accordance with ASX Listing Rule 17.1, pending the release of an
announcement by the Company in relation to safety and toxicity pre-clinical study results on AtremiC.
The Company requests that the trading halt end on the earlier of the commencement of normal trading on Friday
24 July 2020, or when the announcement referred to above is released to the market.
The Company is not aware of any reason why the trading halt should not be granted, nor of any other information
necessary to inform the market about the trading halt, and the Company confirms that the request for a trading
halt is material."
Ann: Trading Halt, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.025(7.94%) |
Mkt cap ! $13.13M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 29.0¢ | $688 | 2.372K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1033 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 11.01am 03/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |